HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sergio Crovella Selected Research

Bacterial Infections (Bacterial Infection)

1/2019Blue laser light inhibits biofilm formation in vitro and in vivo by inducing oxidative stress.
4/2016DEFB1 polymorphisms and susceptibility to recurrent tonsillitis in Italian children.
4/2011Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sergio Crovella Research Topics

Disease

44Infections
02/2024 - 03/2002
22Mevalonate Kinase Deficiency
11/2018 - 02/2007
21Inflammation (Inflammations)
12/2022 - 01/2009
13Hidradenitis Suppurativa
01/2024 - 12/2018
10Neoplasms (Cancer)
01/2024 - 10/2012
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2023 - 09/2007
9Celiac Disease (Celiac Sprue)
02/2015 - 11/2002
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2022 - 06/2011
8HIV Infections (HIV Infection)
01/2019 - 09/2006
7Skin Diseases (Skin Disease)
03/2024 - 12/2018
7COVID-19
01/2023 - 09/2020
6Virus Diseases (Viral Diseases)
05/2024 - 01/2013
6Acquired Immunodeficiency Syndrome (AIDS)
12/2023 - 01/2012
6Autoimmune Diseases (Autoimmune Disease)
01/2020 - 04/2005
5Rheumatoid Arthritis
11/2021 - 01/2016
5Malignant Mesothelioma
01/2021 - 03/2012
5Rare Diseases (Rare Disease)
08/2018 - 06/2010
5Disease Progression
01/2017 - 03/2002
5Papillomavirus Infections
11/2016 - 06/2009
4Mesothelioma
11/2022 - 10/2012
4Disease Susceptibility (Diathesis)
08/2022 - 01/2004
4Communicable Diseases (Infectious Diseases)
08/2022 - 09/2005
4Glioblastoma (Glioblastoma Multiforme)
12/2018 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
03/2024 - 12/2009
3Atopic Dermatitis (Atopic Eczema)
07/2023 - 07/2010
3Pain (Aches)
01/2023 - 10/2019
3Nephritis
06/2022 - 02/2007
3Acne Vulgaris
03/2022 - 12/2018
3Wounds and Injuries (Trauma)
09/2021 - 12/2018
3Hypertrophy
11/2020 - 12/2009
3Neuroinflammatory Diseases
06/2019 - 11/2013
3Bacterial Infections (Bacterial Infection)
01/2019 - 04/2011
3Periodontitis
01/2017 - 09/2014
3Tonsillitis
09/2016 - 11/2009
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2015 - 01/2012
3Coinfection
01/2014 - 08/2011
2Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2024 - 04/2011
2Tuberculosis (Tuberculoses)
01/2024 - 01/2011
2Cardiomyopathies (Cardiomyopathy)
12/2023 - 12/2009
2Nervous System Diseases (Neurological Disorders)
05/2023 - 10/2012
2Dehydration (Water Stress)
02/2023 - 11/2018
2Psoriasis (Pustulosis Palmaris et Plantaris)
03/2022 - 12/2018
2Hypertension (High Blood Pressure)
12/2021 - 12/2009
2Male Infertility (Male Sterility)
10/2020 - 04/2019
2Hypertrophic Cicatrix (Hypertrophic Scar)
02/2020 - 12/2018

Drug/Important Bio-Agent (IBA)

20InflammasomesIBA
01/2024 - 07/2010
17Proteins (Proteins, Gene)FDA Link
03/2024 - 02/2008
16Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2020 - 11/2002
13CytokinesIBA
03/2024 - 07/2011
13Mevalonic Acid (Mevalonate)IBA
11/2018 - 06/2010
8Interleukin-18 (Interleukin 18)IBA
12/2022 - 09/2005
8DefensinsIBA
07/2021 - 01/2004
7VaccinesIBA
02/2024 - 01/2012
7Antimicrobial PeptidesIBA
08/2022 - 07/2010
7mevalonate kinaseIBA
01/2017 - 07/2010
7Terpenes (Terpenoids)IBA
04/2014 - 02/2007
6Peptides (Polypeptides)IBA
01/2024 - 04/2006
6AsbestosIBA
11/2022 - 03/2012
6Calcitriol Receptors (Calcitriol Receptor)IBA
06/2022 - 02/2008
6CholesterolIBA
11/2017 - 06/2010
6HLA-G Antigens (HLA G)IBA
01/2015 - 07/2010
5Antiviral Agents (Antivirals)IBA
11/2023 - 07/2007
5DNA (Deoxyribonucleic Acid)IBA
11/2023 - 01/2014
5beta-DefensinsIBA
11/2020 - 07/2004
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2017 - 03/2010
55' Untranslated Regions (5' UTR)IBA
04/2016 - 08/2006
4NucleotidesIBA
01/2023 - 09/2007
4Vitamin DFDA LinkGeneric
09/2020 - 09/2013
4ChemokinesIBA
01/2016 - 10/2012
4EnzymesIBA
07/2015 - 07/2010
3InterferonsIBA
05/2024 - 01/2016
3MicroRNAs (MicroRNA)IBA
01/2024 - 01/2013
3RNA (Ribonucleic Acid)IBA
08/2022 - 02/2020
3Messenger RNA (mRNA)IBA
06/2022 - 01/2016
3Complement System Proteins (Complement)IBA
01/2022 - 10/2013
3phytobacteriomycin (PBM)IBA
02/2020 - 12/2018
3Interleukin-10 (Interleukin 10)IBA
01/2020 - 02/2012
3Alendronate (Alendronate Sodium)FDA LinkGeneric
02/2018 - 09/2011
3Lovastatin (Mevacor)FDA LinkGeneric
11/2017 - 10/2012
3LigandsIBA
01/2016 - 04/2011
3DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
01/2016 - 11/2012
33' Untranslated Regions (3' UTR)IBA
11/2014 - 07/2010
3geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA
07/2011 - 06/2010
3TransglutaminasesIBA
01/2011 - 11/2002
2Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2017
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2024 - 11/2021
2Pattern Recognition ReceptorsIBA
01/2024 - 04/2011
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2023 - 08/2022
2ParaffinIBA
08/2023 - 11/2022
2Formaldehyde (Formol)FDA Link
08/2023 - 11/2022
2Analgesics (Analgesic Drugs)IBA
05/2023 - 01/2018
2Immunologic Factors (Immunomodulators)IBA
01/2022 - 04/2016
2C-Reactive ProteinIBA
12/2021 - 05/2021
2HLA-C Antigens (HLA-C)IBA
01/2021 - 01/2017

Therapy/Procedure

11Low-Level Light Therapy (LLLT)
01/2023 - 12/2018
10Therapeutics
01/2024 - 02/2007
3Lasers (Laser)
01/2023 - 05/2018
2Drug Therapy (Chemotherapy)
03/2023 - 01/2022
2Radiotherapy
11/2022 - 01/2021
2Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2022